These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15483082)

  • 1. Insulin sensitivity and beta-cell function in protease inhibitor-treated and -naive human immunodeficiency virus-infected children.
    Bitnun A; Sochett E; Dick PT; To T; Jefferies C; Babyn P; Forbes J; Read S; King SM
    J Clin Endocrinol Metab; 2005 Jan; 90(1):168-74. PubMed ID: 15483082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lipids, glucose homeostasis and abdominal adipose tissue distribution in protease inhibitor-treated and naive HIV-infected children.
    Bitnun A; Sochett E; Babyn P; Holowka S; Stephens D; Read S; King SM
    AIDS; 2003 Jun; 17(9):1319-27. PubMed ID: 12799553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
    Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S
    J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-cell dysfunction and low insulin clearance in insulin-resistant human immunodeficiency virus (HIV)-infected patients with lipodystrophy.
    Haugaard SB; Andersen O; Vølund A; Hansen BR; Iversen J; Andersen UB; Nielsen JO; Madsbad S
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):354-61. PubMed ID: 15730419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy.
    Yanovski JA; Miller KD; Kino T; Friedman TC; Chrousos GP; Tsigos C; Falloon J
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1925-31. PubMed ID: 10372688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overweight HIV patients with abdominal fat distribution treated with protease inhibitors are at high risk for abnormalities in glucose metabolism - a reason for glycemic control.
    Blass SC; Ellinger S; Vogel M; Ingiliz P; Spengler U; Stehle P; von Ruecker A; Rockstroh JK
    Eur J Med Res; 2008 May; 13(5):209-14. PubMed ID: 18559303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic abnormalities in HIV type 1-infected children treated and not treated with protease inhibitors.
    Melvin AJ; Lennon S; Mohan KM; Purnell JQ
    AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1117-23. PubMed ID: 11522181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 protease inhibitors induce an increase of triglyceride level in HIV-infected men without modification of insulin sensitivity: a longitudinal study.
    Petit JM; Duong M; Duvillard L; Piroth L; Grappin M; Verges B; Chavanet P; Brun JM; Portier H
    Horm Metab Res; 2000 Sep; 32(9):367-72. PubMed ID: 11014386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women.
    Hadigan C; Miller K; Corcoran C; Anderson E; Basgoz N; Grinspoon S
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1932-7. PubMed ID: 10372689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.
    Behrens G; Dejam A; Schmidt H; Balks HJ; Brabant G; Körner T; Stoll M; Schmidt RE
    AIDS; 1999 Jul; 13(10):F63-70. PubMed ID: 10416516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching to unboosted atazanavir improves glucose tolerance in highly pretreated HIV-1 infected subjects.
    Guffanti M; Caumo A; Galli L; Bigoloni A; Galli A; Dagba G; Danise A; Luzi L; Lazzarin A; Castagna A
    Eur J Endocrinol; 2007 Apr; 156(4):503-9. PubMed ID: 17389467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy.
    Koppel K; Bratt G; Schulman S; Bylund H; Sandström E
    J Acquir Immune Defic Syndr; 2002 Apr; 29(5):441-9. PubMed ID: 11981359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperproinsulinaemia in normoglycaemic lipodystrophic HIV-infected patients.
    Haugaard SB; Andersen O; Hales CN; Halsall I; Rosenfalck AM; Iversen J; Madsbad S
    Eur J Clin Invest; 2006 Jun; 36(6):436-45. PubMed ID: 16684128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum adiponectin and metabolic parameters in HIV-1-infected patients after substitution of nevirapine for protease inhibitors.
    Petit JM; Duong M; Masson D; Buisson M; Duvillard L; Bour JB; Brindisi MC; Galland F; Guiguet M; Gambert P; Portier H; Vergès B
    Eur J Clin Invest; 2004 Aug; 34(8):569-75. PubMed ID: 15305892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients.
    Walli R; Herfort O; Michl GM; Demant T; Jäger H; Dieterle C; Bogner JR; Landgraf R; Goebel FD
    AIDS; 1998 Oct; 12(15):F167-73. PubMed ID: 9814858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel.
    Shalitin S; Abrahami M; Lilos P; Phillip M
    Int J Obes (Lond); 2005 Jun; 29(6):571-8. PubMed ID: 15889115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disorders of glucose metabolism in patients infected with human immunodeficiency virus.
    Dubé MP
    Clin Infect Dis; 2000 Dec; 31(6):1467-75. PubMed ID: 11096014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proinsulin and the proinsulin/insulin ratio in overweight and obese children and adolescents: relation to clinical parameters, insulin resistance, and impaired glucose regulation.
    von Berghes C; Brabant G; Biebermann H; Krude H; Wiegand S
    Pediatr Diabetes; 2011 May; 12(3 Pt 2):242-9. PubMed ID: 21518412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between dyslipidemia and insulin resistance in HIV-infected persons treated with highly active antiretroviral therapy.
    Swanson B; Keithley JK; Zeller JM; Sha BE
    Nutrition; 2004; 20(11-12):1022-5. PubMed ID: 15561494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease therapy and changes to insulin and glucose.
    TreatmentUpdate; 1999 Jun; 11(4):5-6. PubMed ID: 11366792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.